Henlius Wins Chinese Approval For Rituximab RA Indication

Wider Potential Patient Population Allows Firm ‘Differentiated Strategy’

 
• By David Wallace
  
China Flag Thumbs Up
China’s NMPA has approved the Rituxan rival’s RA indication • Source: Micha Klootwijk / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products